UnknownNot Applicable

RECO in the Endovascular Treatment of Acute Ischemic Stroke

China1,000 participantsStarted 2020-05-22

Plain-language summary

Investigate Reco ® ,the first clot retriever in china as the primary therapyand remedies in the real world.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age ≥ 18 years old
. Diagnosis of acute ischemic stroke
. Imaging confirmed intracranial large artery occlusion (LVO): intracranial internal carotid artery (ICA T/L), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral artery (PCA P1);ASPECT or PC-ASPECT ≥ 6
. Initiation of any type of endovascular treatment (EVT), including intra-arterial thrombolysis, mechanical thrombectomy, angioplasty, and stenting
. The patient or the patient's legal representative is able and willing to sign the informed consent

Exclusion criteria

. Isolated cervical ICA or VA occlusion;
. No evidence of LVO on DSA.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Functional independence at 90 days (modified Rankin Scale of 0-2)

Timeframe: [90±7 days after procedure]

Symptomatic intracranial hemorrhage (sICH) within 12-36 hours after the procedure

Timeframe: 12-36 hours after the procedure

Time from symptom onset to recanalization

Timeframe: From the time of symptom onset until the time of of the recanalization of the occluded artery, assessed up to 48 hours

Trial details

NCT IDNCT04840719

SponsorBeijing Tiantan Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

Contact for this trial

Baixue Jia, PhD,MD

86-010-67098857 beckyberry@163.com

View on ClinicalTrials.gov More Intracranial Artery Occlusion With Infarction (Disorder) trials